Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 4, 1997, Pages 391-402

  Decaestecker, Christine ^a   Lopes, M Beatriz S ^e   Gordower, Laurence ^b   Camby, Isabelle ^b,g   Cras, Patrick ^d   Martin, Jean Jacques ^d   Kiss, Robert ^b,f,g   Vandenberg, Scott R ^e   Salmon, Isabelle ^c  

^a Inst Rech Interdisc D   (Belgium)

^b Faculte de Medecine   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

^g FNRS   (Belgium)

Author keywords

Astrocytomas; Computer assisted microscopy; Feulgen staining; Mixed oligoastrocytomas; Oligodendrogliomas; Tumor heterogeneity

Indexed keywords

ARTICLE; ASTROCYTOMA; CANCER GRADING; CHROMATIN STRUCTURE; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC TEST; FEULGEN STAINING; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MACROGLIA; MIXED TUMOR; OLIGODENDROGLIA; PATTERN RECOGNITION; PLOIDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0030725726     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199704000-00008     Document Type: Article

References (33)

1. Kleihues P, Burger PC, Scheithauer BW, eds. Histological typing of tumours of the central nervous system. World Health Organization International Histological Classification of Tumours. 2nd ed. Berlin: Springer Verlag, 1993
2. Burger PC, Scheithauer BW. Tumors of the central nervous system. In: Atlas of Tumor Pathology. AFIP, 1994:142-46
3. Hurtt MR, Moosy J, Donovan-Peluso M, Locker J. Amplification of epidermal growth factor receptor gene in gliomas: Histopathology and prognosis. J Neuropathol Exp Neurol 1992;51:84-90
4. Helseth A, Mork SJ. Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology. Acta Pathol, Microbiol et Immunol Scand 1989;97:547-55
5. Jaskolsky D, Zawirski M, Papierz W, Kotwica Z. Mixed gliomas. Their clinical course and results of surgery. Zent Neurochir 1987;48:120-23
6. Muller W, Afra D, Schroder R. Supratentorial recurrences of gliomas: Morphological studies in relation to time intervals with astrocytomas. Acta Neurochir 1977;37:75-91
7. Russel DS, Rubinstein LJ. Pathology of tumours of the nervous system. 5th ed. London: Edward Arnold, 1989:186
8. Kiss R, Salmon I, Camby I, Gras S, Pasteels JL. Characterisation of factors in routine laboratory protocols which significantly influence the Feulgen reaction. J Histochem Cytochem 1993;41:935-45
9. Salmon I, Rorive S, Camby I, et al. Stereotactic biopsies from astrocytic tumors: Diagnostic information contributed by the quantitative chromatin pattern description. Anal Quant Cytol Histol 1995;17:332-43
10. Decaestecker C, Salmon I, Camby I, et al. Identification of high-vs lower-risk clinical subgroups in the group of adult patients with Supratentorial anaplastic astrocytomas. J Neuropathol Exp Neurol 1995;54:371-84
11. Kros JM, Van Eden CG, Vissers CJ, Mulder AH, Van der Kwast ThH. Prognostic relevance of DNA flow cytometry in the oligodendroglioma. Cancer 1992;69:1791-98
12. Salmon I, Dewitte O, Pasteels JL, et al. Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type. J Neurosurg 1994;80:877-83
13. Ganju U, Jenkins RB, O'Fallon JR, et al. Prognostic factors in gliomas: A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers. Cancer 1994;74:920-27
14. Decaestecker C, van Velthoven R, Petein M, et al. The use of the decision tree technique and image cytometry to characterize aggressiveness in World Health Organization (WHO) grade II superficial transitional cell carcinoma of the bladder. J Pathol 1996;178:274-83
15. Wheeless LL, Badalament RA, de Vere White RW, Fradet Y, Tribukait B. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 1993;14:478-81
16. Kiss R, Gasperin P, Verhest A, Pasteels JL. Modification of tumor ploidy level via the choice of tissue taken as diploid reference in the digital cell image analysis of Feulgen-stained nuclei. Modern Pathol 1992;5:655-60
17. Johnson RA, Wicheren DW. Applied multivariate statistical analysis. 3rd ed. Englewood Cliffs: Prentice-Hall International Editions, 1992
18. Cooper ERA. The relation of oligocytes and astrocytes in cerebral tumours. J Pathol 1935;41:259-66
19. Lantos PL, Kleihues P, VandenBerg SR. Tumours of the nervous system. In: Graham DI and Lantos PL. eds. Greenfield's neuropathology. 6th ed. Edward Arnold, 1996
20. Hart MN, Petito CK, Earle KM. Mixed gliomas. Cancer 1974;33:134-40
21. Burger PC, Scheithauer BW. Tumors of the central nervous system. AFIP atlas of tumor pathology, 3rd series, Fascicle 10, 1994
22. Nakagawa Y, Perentes E, Rubinstein LJ. Immunohistochemical characterization of oligodendrogliomas. An analysis of multiple markers. Acta Neuropathologica 1986;72:15-22
23. Kraus JA, Koopman J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995;54:91-95
24. Levine JM, Stincone F, Lee Y-S. Development and differentiation of glial precursor cells in the rat cerebellum. Glia 1993;7:307-21
25. Noble M, Wren D, Wolswijk G. The O2-A adult progenitor cell: A glial stem cell of the adult central nervous system. Sem Cell Biol 1992;3:413-22
26. Jenjins RB, Kimmel DW, Moertel CA, et al. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 1989;39:253-79
27. Ranson DT, Ritland SR, Kimmel DW, et al. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes, Chromos & Cancer 1992;5:348-56
28. Bello MJ, Vaquero J, de Campo JM, et al. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 1994;57:172-75
29. Kleihues P, Ohgaki H, Eibi RH, et al. Type and frequency of p53 mutations in tumors of the nervous system and its coverings. In: Weiestler OD, Schlegel U, Schramm, eds. Molecular Neuro-oncology and its impact on the clinical management of brain tumors. Berlin: Springer-Verlag, 1994:25-31
30. von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR. Evidence for a tumour suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res 1992;52:4277-79
31. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994;145:1175-90
32. Kiss R, DeWitte O, Decaestecker C. The combined determination of proliferative activity and cell density to identify short-as opposed to long-surviving adult patients with supratentorial high-grade astrocytic tumors. Am J Clin Pathol 1996. Forthcoming
33. Coons SW, Johnson PC. MIB 1/Ki 67 labeling index predicts patient survival for oligodendroglial tumors [abstract]. J Neuropathol Exp Neurol 1995;54:440